Sybil Yang

Sybil joined as Chairman of the Board of Phalanx Biotech Group in 2014. Her successful track record includes having been CEO for Huga Optotech, and growing the company’s market capitalization by 20x during her tenure. Even during the financial crisis of 2008 and 2009, Optatech was rated as one of the “Technology Fast 50” by Deloitte. Prior to that, Sybil was Chief Investment Officer at Yageo, as well as a CFA charter-holder doing industry research, security valuation and portfolio management at Baring Security IIT and Prergnie Securities. She was in charge of Taiwan’s first GDR and Eurobond offerings, working closely with Far Eastern New Century’s CEO and CFO.